Abstract
There is convincing evidence that cytokines are involved in the physiology and pathophysiology of brain function and interact with different neurotransmitter and neuroendocrine pathways. The possible involvement of the immune system in the neurobiological mechanisms that underlie psychiatric disorders has attracted increasing attention in recent years. Thus in the last decade, numerous clinical studies have demonstrated dysregulated immune functions in patients with psychiatric disorders. Such findings formed the basis of the 7th Expert Meeting on Psychiatry and Immunology in Muenster, Germany, where a consensus symposium was held to consider the strengths and weaknesses of current research in psychoneuroimmunology. Following a general overview of the field, the following topics were discussed: (1) methodological problems in laboratory procedures and recruitment of clinical samples; (2) the importance of pre-clinical research and animal models in psychiatric research; (3) the problem of statistical vs biological relevance. It was concluded that, despite a fruitful proliferation of research activities throughout the last decade, the continuous elaboration of methodological standards including the implementation of hypothesis-driven research represents a task that is likely to prove crucial for the future development of immunology research in clinical psychiatry.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lehmann-Facius H . Liquoruntersuchungen bei destruktiven Erkrankungen des Nervensystems, besonders bei Schizophrenien Neurol Psychiatrie 1937; 157: 109–115
Stein M, Miller AH, Trestman RL . Depression, the immune system, and health and illness. Findings in search of meaning Arch Gen Psychiatry 1991; 48: 171–177
Kirch DG . Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal Schizophr Bull 1993; 19: 355–370
Dantzer R, Wollman E, Vitkovic L, Yirmiya R . Cytokines and depression: fortuitous or causative association? Mol Psychiatry 1999; 4: 328–332
Capuron L, Ravaud A, Dantzer R . Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alpha-2b therapy J Clin Oncol 2000; 18: 2143–2151
Villemain F, Chatenoud L, Galinowski A, Homo-Delarche F, Ginestet D, Loo H et al. Aberrant T-cell mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production Am J Psychiatry 1989; 146: 609–616
Ganguli R, Brar JS, Chengappa KNR, DeLeo M, Yang ZW, Shurin G, Rabin BS . Mitogen-stimulated interleukin-2 production in never-medicated, first episode schizophrenic patients Arch Gen Psychiatry 1995; 52: 668–671
Arolt V, Rothermundt M, Wandinger KP, Kirchner H . Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment Mol Psychiatry 2000; 5: 150–158
Rothermundt M, Arolt V, Leadbeater J, Peters M, Rudolf S, Kirchner H . Cytokine production in unmedicated and treated schizophrenic patients Neuroreport 2000; 11: 3385–3388
Rapaport MH, McAllister CG, Pickar D, Tamarkin L, Kirch DG, Paul SM . CSF IL-1 and IL-2 in medicated schizophrenic patients and normal volunteers Schizophr Res 1997; 25: 123–129
Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH . Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients Am J Psychiatry 1993; 150: 1408–1410
McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME et al. Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status Am J Psychiatry 1995; 152: 1291–1297
Rapaport MH, McAllister CG, Pickar D, Nelson DL, Paul SM . Elevated levels of soluble interleukin-2 receptors in schizophrenia Arch Gen Psychiatry 1989; 46: 291–292
Rapaport MH, Lohr JB . Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia Acta Psychiatr Scand 1994; 90: 311–315
Schwarz MJ, Riedel M, Gruber R, Ackenheil M, Muller N . Antibodies to heat shock proteins in schizophrenic patients: implications for the mechanism of the disease Am J Psychiatry 1999; 156: 1103–1104
Müller N, Riedel M, Hadjamu M, Schwarz MJ, Ackenheil M, Gruber R . Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood–brain barrier permeability in schizophrenia Am J Psychiatry 1999; 156: 634–636
Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kuhn M, Schuld A, Pollmacher T . Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis J Psychiatr Res 1999; 33: 407–418
Pollmacher T, Haack M, Schuld A, Kraus T, Hinze-Selch D . Effects of antipsychotic drugs on cytokine networks J Psychiatr Res 2000; 34: 369–382
Yolken RH, Karlsson H, Yee F, Johnston-Wilson NL, Torrey EF . Endogenous retroviruses and schizophrenia Brain Res Brain Res Rev 2000; 31: 193–199
van West D, Maes M . Activation of the inflammatory response system: a new look at the etiopathogenesis of major depression Neuroendocrinol Lett 1999; 20: 11–17
Licinio J, Wong ML . The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection Mol Psychiatry 1999; 4: 317–327
Prolo P, Licinio J . Cytokines in affective disorders and schizophrenia: new clinical and genetic findings Mol Psychiatry 1999; 4: 396
Leonard BE . The immune system, depression and the action of antidepressants Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 767–780
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arolt, V., Rothermundt, M., Peters, M. et al. Immunological research in clinical psychiatry: report on the consensus debate during the 7th expert meeting on psychiatry and immunology. Mol Psychiatry 7, 822–826 (2002). https://doi.org/10.1038/sj.mp.4001115
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001115